What is PictorLabs?
Founded in 2019 and headquartered in Los Angeles, PictorLabs leverages artificial intelligence to enhance digital pathology, focusing on histopathology and clinical research applications. The company's technology aims to improve the accuracy and efficiency of diagnostic processes, providing critical insights for healthcare providers and researchers. By integrating advanced AI algorithms with pathology workflows, PictorLabs is positioned to address key challenges in disease detection and treatment monitoring, contributing to the evolution of precision medicine.
How much funding has PictorLabs raised?
PictorLabs has raised a total of $45.2M across 2 funding rounds:
Unspecified
$15.2M
Series B
$30M
Unspecified (2022): $15.2M with participation from M Ventures, Soft Computer Consultants, and Koç Holding
Series B (2024): $30M led by M/ventures and Insight Partners
Key Investors in PictorLabs
M/ventures
M/ventures is a dynamic investment arm of M/CAPITAL PARTNERS that brings together smart money and promising startups. They help young companies grow by providing funding and guidance across different industries. With a keen eye for potential, the team supports entrepreneurs who want to turn their bold ideas into real businesses.
Insight Partners
Insight Partners is a global venture capital and private equity firm that invests in high-growth software and technology companies. It provides capital and hands-on operational support to help businesses scale from early stage to IPO, focusing on enterprise software, SaaS, and internet platforms.
Koç Holding
Koç Holding is Turkey's industrial conglomerate with diverse interests including automotive, consumer goods, energy, and finance. Their investment in PictorLabs suggests a strategic interest in the burgeoning health-tech sector.
What's next for PictorLabs?
The substantial enterprise-level funding and recent strategic investment signal a strong commitment to PictorLabs' expansion and technological development. This capital infusion is expected to accelerate the company's research and development initiatives, potentially leading to new product launches and broader market penetration. PictorLabs is likely to focus on scaling its operations, enhancing its AI capabilities, and forging strategic partnerships within the healthcare and pharmaceutical sectors. The company's growth trajectory suggests a move towards further commercialization and establishing a dominant presence in the digital pathology market.
See full PictorLabs company page
